journal article·2017-01

Detailed profiling on DNA binding affinity, cytotoxicity and pathway of induced cell death of novel water-soluble Cu(Ⅱ)-based acylhydrazone porphyrin derivatives

Xiao-Xia Feng, Jun-Xiang Zhang, Yu Wu, Qian Zhang, Jia-Cheng Liu

Dyes and Pigments· Volume 136
Publisher page

Abstract

Abstract A panel of novel water-soluble Cu(Ⅱ)-based acylhydrazone porphyrin complexes (denoted as Cu-PorX, X = 1, 2 and 3. See Fig. 1) were prepared and characterized. Versatile physicochemical approaches indicated that whole compounds could effectively bind with ct-DNA through intercalative or intercalative coupled with end-stacking interaction, especially, Cu-Por3 has the strongest binding affinity compared with others. Additionally, the antiproliferative activity has been evaluated by MTT assay turned out that Cu-Por3 yet exhibits gratifying cytotoxicity towards A549 (non-small cell lung cancer) cell line, suggesting that Cu-Por3 is a potential candidacy among tested agents. We also carried out the cellular uptake measurement by using an extracted method to better comprehend the anticancer behaviors. Moreover, for gaining deeper insight into the mechanism of cell death of affected by the representative complex Cu-Por3, the influences of this new conjugate on the cell cycle and the induction of apoptosis were illustrated via employing flow cytometric analysis.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Metal complexes synthesis and properties · DNA and Nucleic Acid Chemistry · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Platinum compounds: a new class of potent antitumor agents10.1038/222385a0 ↗
2. Improved understanding in platinum antitumour chemistry10.1039/cc9960000801 ↗
3. Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA10.1016/j.ccr.2009.01.028 ↗
4. Tumour-inhibiting platinum complexes- state of the art and future perspectives10.1007/s10254-002-0001-x ↗
5. Recent developments in the field of tumor-inhibiting metal complexes10.2174/1381612033454180 ↗
6. Ruthenium porphyrin compounds for photodynamic therapy of cancer10.1021/jm701382p ↗
7. New trends for metal complexes with anticancer activity10.1016/j.cbpa.2007.11.013 ↗
8. A novel cytotoxic ternary copper(II) complex of 1,10-phenanthroline and L-threonine with DNA nuclease activity10.1016/j.jinorgbio.2004.09.014 ↗
9. Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity10.1021/ic700755p ↗
10. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity10.1021/ic801144x ↗
11. Advances in copper complexes as anticancer agents10.1021/cr400135x ↗
12. Geraki K, Farquharson MJ, Bradley DA. Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys Med Biol 2002; 47: 2327–2399.10.1088/0031-9155/47/13/310 ↗
13. Copper and ceruloplasmin status in serum of prostate and colon cancer patients
14. Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors10.1007/BF01324697 ↗
15. Serum and tissue trace metal levels in lung cancer10.1159/000226722 ↗
16. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo [3,2-c]quinoline ligands10.1021/ic101633z ↗
17. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis10.1021/ic1024185 ↗
18. Design, preparation, and characterization of Zn and Cu metallopeptides based on tetradentate aminopyridine ligands showing enhanced DNA cleavage activity10.1021/acs.inorgchem.5b01680 ↗
19. Developing anticancer copper(II) pro-drugs based on the nature of cancer cells and the human serum albumin carrier IIA subdomain10.1021/acs.molpharmaceut.5b00314 ↗
20. L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity10.1021/ic300967j ↗
21. Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture10.1093/jac/dki481 ↗
22. Bioactive pyridine-N-oxide disulfides from allium stipitatum10.1021/np800572r ↗
23. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducer in human breast cancer cells10.1186/bcr1322 ↗
24. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt (Ⅱ), copper (Ⅱ) and zinc (Ⅱ) coordination compounds with 2-substituted benzimidazoles10.1016/j.jinorgbio.2009.05.018 ↗
25. Mechanism of action of coumarin and silver(I)–coumarin complexes against the pathogenic yeast Candida albicans10.1016/j.tiv.2007.01.022 ↗
26. Synthesis and reactivity studies on new copper(II) complexes: DNA binding, generation of phenoxyl radical, SOD and nuclease activities10.1016/j.ejmech.2010.05.026 ↗
27. Nuclease activity via self-activation and anticancer activity of a mononuclear copper(II) complex: novel role of the tertiary butyl group in the ligand frame10.1021/ic2016676 ↗
28. Structural studies and anticancer activity of a novel (N6O4) macrocyclic ligand and its Cu(II) complexes10.1016/j.saa.2010.10.021 ↗
29. New porphyrins bearing positively charged peripheral groups linked by a sulfonamide group to meso-tetraphenylporphyrin: interactions with calf thymus DNA10.1021/ic900385y ↗
30. Porphyrin- cyclodextrin conjugates as a nanosystem for versatile drug delivery and multimodal cancer therapy10.1021/jm9007278 ↗
31. meso-Tetrakis (p-sulfonatophenyl) N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy10.1021/jm300009q ↗
32. Sugar and heavy atom effects of glycoconjugated chlorin palladium complex on photocytotoxicity10.1021/bc300223j ↗
33. Tetranuclear gadolinium(III) porphyrin complex as a theranostic agent for multimodal imaging and photodynamic therapy10.1021/ic500238s ↗
34. Tris-ruthenium(II)/copper(II) multimetallic porphyrin: synthesis, characterization, DNA binding and supercoiled DNA photocleavage studies10.1016/j.ica.2009.10.019 ↗
35. Cationic copper(II) porphyrins intercalate into domains of doublestranded RNA10.1021/bi300828z ↗
36. DNA-binding studies of a tetraalkyl- substituted porphyrin and the mutually adaptive distortion principle10.1021/ic501683t ↗
37. Internal versus external binding of cationic porphyrins to singlestranded DNA10.1021/ic403105q ↗
38. G-quadruplex DNA interactions, docking and cell photocytotoxicity research of porphyrin dyes10.1016/j.dyepig.2016.01.009 ↗
39. Effects of compound structure on carbazole dication-DNA complexes: tests of the minor-groove complex models10.1021/bi001236i ↗
40. Synthesis, characterization and studies on DNA- binding of a new Cu(II) complex with N1, N8-bis (l-methyl-4-nitropyrrole-2-carbonyl) triethylenetetramine10.1016/j.jinorgbio.2006.07.011 ↗
41. A spectroscopic study on the interactions of porphyrin with G-Quadruplex DNAs10.1021/bi052356z ↗
42. Voltammetric studies of the interaction of metal chelates with DNA. 2. tris-chelated complexes of Cobalt(Ⅲ) and Iron(Ⅱ) with 1,l0-phenanthroline and 2,2'-bipyridine10.1021/ja00206a020 ↗
43. On demonstrating DNA intercalation10.1021/ar00177a001 ↗
44. Synthesis, crystal structure, DNA interaction and antioxidant activities of two novel water-soluble Cu(2+) complexes derivated from 2-oxo-quinoline-3-carbaldehyde Schiff-bases10.1016/j.ejmech.2009.06.009 ↗
45. Interaction of porphyrins with nucleic acids10.1021/bi00279a016 ↗
46. Tris(phenanthroline)ruthenium(Ⅱ) enantiomer interactions with DNA: mode and specificity of binding10.1021/bi00061a015 ↗
47. Porphyrin-bile acid conjugates: from saccharide recognition in the solution to the selective cancer cell fluorescence detection10.1039/b717528k ↗
48. Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin10.1016/j.ejmech.2014.08.071 ↗